Xonia Carvajal-Vergara

Xonia Carvajal-Vergara

UNVERIFIED PROFILE

Are you Xonia Carvajal-Vergara?   Register this Author

Register author
Xonia Carvajal-Vergara

Xonia Carvajal-Vergara

Publications by authors named "Xonia Carvajal-Vergara"

Are you Xonia Carvajal-Vergara?   Register this Author

17Publications

507Reads

22Profile Views

Generation of two transgene-free human iPSC lines from CD133 cord blood cells.

Stem Cell Res 2019 04 28;36:101410. Epub 2019 Feb 28.

Inbiomed Foundation, San Sebastian, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2019.101410DOI Listing
April 2019

Generation of four Isl1 reporter iPSC lines from cardiac and tail-tip fibroblasts derived from Ai6IslCre mouse.

Stem Cell Res 2018 12 11;33:125-129. Epub 2018 Oct 11.

Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2018.10.013DOI Listing
December 2018

Generation of Macaca fascicularis iPS cell line ATCi-MF1 from adult skin fibroblasts using non-integrative Sendai viruses.

Stem Cell Res 2017 05 16;21:1-4. Epub 2017 Mar 16.

Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, Health Research Institute of Navarra, Pamplona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2017.03.008DOI Listing
May 2017

Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.

Stem Cell Reports 2016 10 22;7(4):602-618. Epub 2016 Sep 22.

Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Casanova 143, 08036 Barcelona, Spain; Department of Biomedicine, School of Medicine, University of Barcelona, 08036 Barcelona, Spain; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), 08036 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stemcr.2016.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063541PMC
October 2016

Are we closer to cardiac regeneration?

Stem Cell Investig 2016 20;3:59. Epub 2016 Oct 20.

Cell Therapy Program, Foundation for Applied Medical Research, University of Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain;; Cell Therapy Area, Clínica Universidad de Navarra, University of Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/sci.2016.09.16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104586PMC
October 2016

Generation of iPSC from cardiac and tail-tip fibroblasts derived from a second heart field reporter mouse.

Stem Cell Res 2016 05 19;16(3):617-21. Epub 2016 Mar 19.

Cell Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2016.03.006DOI Listing
May 2016

High-purity enrichment of functional cardiovascular cells from human iPS cells.

Cardiovasc Res 2012 Aug 6;95(3):327-35. Epub 2012 Jun 6.

Department of Developmental Biology, University of Pittsburgh School of Medicine, 530 45th Street, Rangos Research Center, Pittsburgh, PA 15201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cvr/cvs185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415083PMC
August 2012

Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders.

Curr Opin Cardiol 2011 May;26(3):223-9

Child Health and Development Institute, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCO.0b013e32834598adDOI Listing
May 2011

Mechanism of apoptosis induced by IFN-alpha in human myeloma cells: role of Jak1 and Bim and potentiation by rapamycin.

Cell Signal 2007 Apr 8;19(4):844-54. Epub 2006 Dec 8.

Departamento de Bioquimica, Biologia Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, 50009 Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S089865680600289
Publisher Site
http://dx.doi.org/10.1016/j.cellsig.2006.10.009DOI Listing
April 2007

The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.

Cancer Res 2006 Jun;66(11):5781-9

Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Cientificas, Universidad de Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-4186DOI Listing
June 2006

Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents.

Br J Haematol 2003 Dec;123(5):858-68

Centro de Investigación del Cáncer, Instituto de Microbiología Bioquímica, and Hospital Universitario de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04706.xDOI Listing
December 2003